Abstract
Anorexia nervosa (AN) and bulimia nervosa (BN) are serious psychiatric illnesses that often first appear in adolescence. These eating disorders are driven by body shape and weight concerns, are associated with a number of serious medical and psychiatric features, and have mortality rates among the highest of all psychiatric illnesses (Sullivan, Am J Psychiatr 152(7): 1073–1074, 1995). It is important to identify them quickly, as these illnesses worsen over time and are most successfully treated soon after the onset of symptoms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association [APA]. (1952). Diagnostic and statistical manual of mental disorders (1st ed.). Washington, DC: Author.
American Psychiatric Association. (1968). Diagnostic and statistical manual of mental disorders (2nd ed.). Washington, DC: Author.
American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., revised). Washington, DC: Author.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: Author.
Attia, E., Haiman, C., Walsh, B. T., & Flater, S. R. (1998). Does fluoxetine augment the inpatient treatment of anorexia nervosa? The American Journal of Psychiatry, 155(4), 548–551.
Attia, E., Kaplan, A. S., Walsh, B. T., Gershkovich, M., Yilmaz, Z., Musante, D., & Wang, Y. (2011). Olanzapine versus placebo for outpatients with anorexia nervosa. Psychological Medicine, 41(10), 2177–2182.
Attia, E., & Roberto, C. A. (2009). Should amenorrhea be a diagnostic criterion for anorexia nervosa? The International Journal of Eating Disorders, 42, 581–589.
Attia, E., & Walsh, B. T. (2009). Behavioral management for anorexia nervosa. The New England Journal of Medicine, 360, 500–506.
Becker, A. E., Burwell, R. A., Gilman, S. E., Herzog, D. B., & Hamburg, P. (2002). Eating behaviours and attitudes following prolonged exposure to television among ethnic Fijian adolescent girls. The British Journal of Psychiatry, 180, 509–514.
Bell, R. M. (1985). Holy anorexia. Chicago, IL: University of Chicago Press.
Biederman, J., Herzog, D. B., Rivinus, T. M., Harper, G. P., Ferber, R. A., Rosenbaum, J. F., … Schildkraut, J. J. (1985). Amitriptyline in the treatment of anorexia nervosa: A double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology, 5(1), 10–16.
Birmingham, C. L., Goldner, E. M., & Bakan, R. (1994). Controlled trial of zinc supplementation in anorexia nervosa. The International Journal of Eating Disorders, 15, 251.
Bissada, H., Tasca, G., Barber, A., & Bradwejn, J. (2008). Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: A randomized, double-blind, placebo-controlled trial. The American Journal of Psychiatry, 165(10), 1281–1288.
Boachie, A., Goldfield, G., & Spettigue, W. (2003). Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: Case reports. The International Journal of Eating Disorders, 33(1), 98–103.
Boyer, T. W. (2006). The development of risk-taking: A multi-perspective review. Developmental Review, 26(3), 291–345.
Brambilla, F., Garcia, C. S., Fassino, S., Daga, G. A., Favaro, A., Santonastaso, P., … Monteleone, P. (2007). Olanzapine therapy in anorexia nervosa: Psychobiological effects. International Clinical Psychopharmacology, 22(4), 197–204.
Bulik, C. M., Sullivan, P., Fear, J., Pickering, A., Dawn, A., & McCullin, M. (1999). Fertility and reproduction in women with a history of anorexia nervosa: A controlled study. Journal of Clinical Psychiatry, 60(2), 130–135.
Bulik, C. M., Sullivan, P. F., Joyce, P. R., & Carter, F. A. (1995a). Temperament, character, and personality disorder in bulimia nervosa. The Journal of Nervous and Mental Disease, 183(9), 593–598.
Bulik, C. M., Sullivan, P., Tozzi, F., Furberg, H., Lichtenstein, P., & Pedersen, N. (2006). Prevalence, heritability and prospective risk factors for anorexia nervosa. Archives of General Psychiatry, 63(1), 305–312.
Bulik, C. M., Sullivan, P. F., Weltzin, T. E., & Kaye, W. H. (1995b). Temperament in eating disorders. The International Journal of Eating Disorders, 17(3), 251–261.
Call, C., Walsh, B. T., & Attia, E. (2013). From DSM-IV to DSM-5: Changes to eating disorder diagnoses. Current Opinion in Psychiatry, 26(6), 532–536.
Carter, J. C., Mercer-Lynn, K. B., Norwood, S. J., Bewell-Weiss, C. V., Crosby, R. D., Woodside, D. B., & Olmsted, M. P. (2012). A prospective study of predictors of relapse in anorexia nervosa: Implications for relapse prevention. Psychiatry Research, 200(2-3), 518–523.
Casper, R. C., Hedeker, D., & McClough, J. F. (1992). Personality dimensions in eating disorders and their relevance for subtyping. Journal of the American Academy of Child and Adolescent Psychiatry, 31(5), 830–840.
Cooper, Z., & Stewart, A. (2008). CBT-E and the younger patient. In C. G. Fairburn (Ed.), Cognitive behavior therapy and eating disorders (pp. 221–230). New York, NY: Guilford Press.
Crisp, A. H., Norton, K., Gowers, S., Halek, C., Bowyer, C., Yeldham, D., … Bhat, A. (1991). A controlled study of the effect of therapies aimed at adolescent and family psychopathology in anorexia nervosa. The British Journal of Psychiatry, 159, 325–333.
Dalle Grave, R., Calugi, S., El Ghoch, M., Conti, M., & Fairburn, C. G. (2014). Inpatient cognitive behavior therapy for adolescents with anorexia nervosa: Immediate and longer-term effects. Frontiers in Psychiatry, 5, 14.
Devlin, M. J., Kissileff, H. R., Zimmerli, E. J., Samuels, F., Chen, B. E., Brown, A. J., … Walsh, B. T. (2012). Gastric emptying and symptoms of bulimia nervosa: Effect of a prokinetic agent. Physiology & Behavior, 106(2), 238–242.
Devlin, M. J., Walsh, B. T., Guss, J. L., Kissileff, H. R., Liddle, R. A., & Petkova, E. (1997). Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. The American Journal of Clinical Nutrition, 65(1), 114–120.
Eisler, I., Dare, C., Russell, G. F. M., Szmukler, G. I., Le Grange, D., & Dodge, E. (1997). Family and individual therapy in anorexia nervosa: A five-year follow-up. Archives of General Psychiatry, 54, 1025–1030.
Fairburn, C. G. (2008). Cognitive behavior therapy and eating disorders. New York, NY: Guilford Press.
Fairburn, C. G., Jones, R., Peveler, R. C., Hope, R. A., & O'Connor, M. (1993). Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy. Archives of General Psychiatry, 50(6), 419–428.
Faris, P. L., Kim, S. W., Meller, W. H., Goodale, R. L., Oakman, S. A., Hofbauer, R. D., … Hartman, B. K. (2000). Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: A randomised, double-blind trial. Lancet, 355(9206), 792–797.
Freidl, E. K., Keegan, K. A., Richter, D., Mayer, L. E. S., & Attia, E. (2014). Intensive treatment for eating disorders. In G. O. Gabbard (Ed.), Treatments of psychiatric disorders (DSM-5 ed.) (pp. 561–570). Arlington, VA: American Psychiatric Publishing.
Geliebter, A., Melton, P. M., McCray, R. S., Gallagher, D. R., Gage, D., & Hashim, S. A. (1992). Gastric capacity, gastric emptying, and test-meal intake in normal and bulimic women. The American Journal of Clinical Nutrition, 56(4), 656–661.
Goldberg, S. C., Halmi, K. A., Eckert, E. D., et al. (1979). Cyproheptadine in anorexia nervosa. The British Journal of Psychiatry, 134, 67.
Golden, N. H., & Attia, E. (2011). Psychopharmacology of eating disorders in children and adolescents. Pediatric Clinics of North America, 58(1), 121–138.
Goldstein, D. J., Wilson, M. G., Ascroft, R. C., & Al-Banna, M. (1999). Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression. The International Journal of Eating Disorders, 25(1), 19–27.
Gordon, R. A. (2000). Eating disorders: Anatomy of a social epidemic (2nd ed.). Oxford, UK: Blackwell.
Gross, H. A., Ebert, M. H., Faden, V. B., Goldberg, S. C., Kaye, W. H., Caine, E. D., … Zinberg, N. (1983). A double-blind trial of delta9-tetrahydrocannabinol in primary anorexia nervosa. Journal of Clinical Psychopharmacology, 3(3), 165–171.
Gross, H. A., Ebert, M. H., Faden, V. B., Goldberg, S. C., Nee, L. E., & Kaye, W. H. (1981). A double-blind controlled trial of lithium carbonate in primary anorexia nervosa. Journal of Clinical Psychopharmacology, 1, 376.
Guarda, A. S., & Heinberg, L. J. (2004). Inpatient and partial hospital approaches to the treatment of eating disorders. In J. K. Thompson (Ed.), Handbook of eating disorders and obesity (pp. 297–322). Hoboken, NJ: John Wiley.
Halmi, K. A., Agras, W. S., Mitchell, J., Wilson, G. T., Crow, S., Bryson, S. W., & Kraemer, H. (2002). Relapse predictors of patients with bulimia nervosa who achieved abstinence through cognitive behavioral therapy. Archives of General Psychiatry, 59(12), 1105–1109.
Heaner, M. K., & Walsh, B. T. (2013). A history of the identification of the characteristic eating disturbances of bulimia nervosa, binge eating disorder, and anorexia nervosa. Appetite, 71, 445–448.
Herzog, D. B., Dorer, D. J., Keel, P. K., Selwyn, S. E., Ekeblad, E. R., Flores, A. T., … Keller, M. B. (1999). Recovery and relapse in anorexia and bulimia nervosa: A 7.5 year follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 38(7), 829–837.
Holtkamp, K., Konrad, K., Kaiser, N., Ploenes, Y., Heussen, N., Grzella, I., & Herpertz-Dahlmann, B. (2005). A retrospective study of SSRI treatment in adolescent anorexia nervosa: Insufficient evidence for efficacy. Journal of Psychiatric Research, 39(3), 303–310.
Horne, R. L., Ferguson, J. M., Pope Jr., H. G., Hudson, J. I., Lineberry, C. G., Ascher, J., & Cato, A. (1988). Treatment of bulimia with bupropion: A multicenter controlled trial. The Journal of Clinical Psychiatry, 49(7), 262–266.
Hudson, J. I., Hiripi, E., Pope Jr., H. G., & Kessler, R. C. (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61(3), 348–358.
Hughes, P. L., Wells, L. A., Cunningham, C. J., & Ilstrup, D. M. (1986). Treating bulimia with desipramine: A double-blind, placebo- controlled study. Archives of General Psychiatry, 43, 182.
Kaplan, A. S., Walsh, B. T., Olmsted, M., Attia, E., Carter, J. C., Devlin, M. J., … Parides, M. (2009). The slippery slope: Prediction of successful weight maintenance in anorexia nervosa. Psychological Medicine, 39(6), 1037–1045.
Kennedy, S., Goldbloom, D., Ralevski, E., Davis, C., D’Souza, J., & Lofchy, J. (1993). Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. Journal of Clinical Psychopharmacology, 13(6), 415–422.
Kerem, N. C., & Katzman, D. K. (2003). Brain structure and function in adolescents with anorexia nervosa. Adolescent Medicine, 14(1), 109–118.
Keys, A., Brozek, J., Henschel, A., Mickelsen, O., & Taylor, H. L. (1950). The biology of human starvation. Minneapolis, MN: University of Minnesota Press.
Kissileff, H. R., Wentzlaff, T. H., Guss, J. L., Walsh, B. T., Devlin, M. J., & Thornton, J. C. (1996). A direct measure of satiety disturbance in patients with bulimia nervosa. Physiology & Behavior, 60(4), 1077–1085.
Kotler, L. A., Devlin, M. J., Davies, M., & Walsh, B. T. (2003). An open trial of fluoxetine for adolescents with bulimia nervosa. Journal of Child and Adolescent Psychopharmacology, 13(3), 329–335.
Lacey, J., & Crisp, A. (1980). Hunger, food intake and weight: The impact of clomipramine on a refeeding anorexia nervosa population. Postgraduate Medical Journal, 56(Suppl 1), 79–85.
Le Grange, D., Crosby, R. D., Engel, S. G., Cao, L., Ndungu, A., Crow, S. J., … Wonderlich, S. A. (2013). DSM-IV-defined anorexia nervosa & versus subthreshold anorexia nervosa (EDNOS-AN). European Eating Disorders Review, 21(1), 1–7.
Le Grange, D., Crosby, R. D., Rathouz, P. J., & Leventhal, B. L. (2007). A randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa. Archives of General Psychiatry, 64(9), 1049–1056.
Le Grange, D., Eisler, I., Dare, C., & Russell, G. F. M. (1992). Evaluation of family treatments in adolescent anorexia nervosa: A pilot study. The International Journal of Eating Disorders, 12, 347–357.
Le Grange, D., & Lock, J. (2007). Treating adolescent bulimia: A family-based approach. New York, NY: Guilford Press.
Le Grange, D., Swanson, S. A., Crow, S. J., & Merikangas, K. R. (2012). Eating disorder not otherwise specified presentation in the US population. The International Journal of Eating Disorders, 45(5), 711–718.
Lock, J., & Le Grange, D. (2013). Treatment manual for anorexia nervosa: A family-based approach (2nd ed.). New York, NY: Guilford Press.
Lock, J., Le Grange, D., Agras, W. S., Moye, A., Bryson, S. W., & Jo, B. (2010). Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa. Archives of General Psychiatry, 67(10), 1025–1032.
Loeb, K. L., Hirsch, A. M., Greif, R., & Hildebrandt, T. B. (2009). Family-based treatment of a 17-year-old twin presenting with emerging anorexia nervosa: A case study using the “Maudsley method”. Journal of Clinical Child and Adolescent Psychology, 38(1), 176–183.
Loeb, K. L., Walsh, B. T., Lock, J., Le Grange, D., Jones, J., Marcus, S., … Dobrow, I. (2007). Open trial of family-based treatment for full and partial anorexia nervosa in adolescence: Evidence of successful dissemination. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7), 792–800.
Machado, P. P., Gonçalves, S., & Hoek, H. W. (2013). DSM-5 reduces the proportion of EDNOS cases: Evidence from community samples. The International Journal of Eating Disorders, 46(1), 60–65.
Marrazzi, M. A., Bacon, J. P., Kinzie, J., et al. (1995). Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. International Clinical Psychopharmacology, 10(3), 163.
McIntosh, V. V., Jordan, J., Carter, F. A., Luty, S. E., McKenzie, J. M., Bulik, C. M., … Joyce, P. R. (2005). Three psychotherapies for anorexia nervosa: A randomized, controlled trial. The American Journal of Psychiatry, 162(4), 741–747.
Mehanna, H. M., Moledina, J., & Travis, J. (2008). Refeeding syndrome: What is it, and how to prevent and treat it. BMJ, 336(7659), 1495–1498.
Mehler, C., Wewetzer, C., Schulze, U., Warnke, A., Theisen, F., & Dittmann, R. W. (2001). Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases. European Child & Adolescent Psychiatry, 10(2), 151–157.
Mehler, P. S., Winkelman, A. B, Andersen, D. M., & Gaudiani, J. L. (2010). Nutritional rehabilitation: Practical guidelines for refeeding the anorectic patient. Journal of Nutrition and Metabolism, 2010.
Minuchin, S., Baker, L., Rosman, B., Liebman, R., Milman, L., & Todd, T. (1975). A conceptual model of psychosomatic illness in children. Family organization and family therapy. Archives of General Psychiatry, 32(8), 1031–1038.
Mitchell, J. E., Agras, W. S., Wilson, G. T., Halmi, K., Kraemer, H., & Crow, S. (2004). A trial of a relapse prevention strategy in women with bulimia nervosa who respond to cognitive-behavior therapy. The International Journal of Eating Disorders, 35(4), 549–555.
Mitchell, J. E., & Groat, R. (1984). A placebo-controlled, double-blind trial of amitriptyline in bulimia. Journal of Clinical Psychopharmacology, 4(4), 186–193.
National Institutes of Health. (2015). Research portfolio online reporting tools: Olanzapine versus Placebo in outpatients with Anorexia nervosa. Retrieved from http://projectreporter.nih.gov/project_info_description.cfm?projectnumber=5R01MH085921-05
Nickel, C., Tritt, K., Muehlbacher, M., Pedrosa Gil, F., Mitterlehner, F. O., Kaplan, P., … Nickel, M. K. (2005). Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial. The International Journal of Eating Disorders, 38(4), 295–300.
Ornstein, R. M., Rosen, D. S., Mammel, K. A., Callahan, S. T., Forman, S., Jay, M. S., … Walsh, B. T. (2013). Distribution of eating disorders in children and adolescents using the proposed DSM-5 criteria for feeding and eating disorders. Journal of Adolescent Health, 53(2), 303–305.
Pike, K. M., Walsh, B. T., Vitousek, K., Wilson, G. T., & Bauer, J. (2003). Cognitive behavior therapy in the posthospitalization treatment of anorexia nervosa. The American Journal of Psychiatry, 160(11), 2046–2049.
Pinheiro, A. P., Root, T., & Bulik, C. M. (2009). The genetics of anorexia nervosa: Current findings and future perspectives. International Journal of Child and Adolescent Health, 2(2), 153–164.
Robinson, S., Perkins, S., Bauer, S., Hammond, N., Treasure, J., & Schmidt, U. (2006). Aftercare intervention through text messaging in the treatment of bulimia nervosa--feasibility pilot. The International Journal of Eating Disorders, 39(8), 633–638.
Romano, S. J., Halmi, K. A., Sarkar, N. P., Koke, S. C., & Lee, J. S. (2002). A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. The American Journal of Psychiatry, 159(1), 96–102.
Ruiz, M. C., & Soler-Gonzalez, J. (2005). Unfortunate ingestion. The New England Journal of Medicine, 353, 2270.
Russel, G. (1979). Bulimia nervosa: An ominous variant of anorexia nervosa. Psychological Medicine, 9(3), 429–448.
Shapiro, J. R., Berkman, N. D., Brownley, K. A., Sedway, J. A., Lohr, K. N., & Bulik, C. M. (2007). Bulimia nervosa treatment: A systematic review of randomized controlled trials. The International Journal of Eating Disorders, 40(4), 321–336.
Stacher, G., Abatzi-Wenzel, T. A., Wiesnagrotzki, S., Bergmann, H., Schneider, C., & Gaupmann, G. (1993). Gastric emptying, body weight and symptoms in primary anorexia nervosa: Long term effects of cisapride. The British Journal of Psychiatry, 162, 398–402.
Steinglass, J. E., Kaplan, S. C., Liu, Y., Wang, Y., & Walsh, B. T. (2014). The (lack of) effect of alprazolam on eating behavior in anorexia nervosa: A preliminary report. The International Journal of Eating Disorders, 47(8), 901–904.
Sullivan, P. F. (1995). Mortality in anorexia nervosa. The American Journal of Psychiatry, 152(7), 1073–1074.
Sysko, R., Sha, N., Wang, Y., Duan, N., & Walsh, B. T. (2010). Early response to antidepressant treatment in bulimia nervosa. Psychological Medicine, 40(6), 999–1005.
Trace, S. E., Thornton, L. M., Root, T. L., Mazzeo, S. E., Lichtenstein, P., Pedersen, N. L., & Bulik, C. M. (2012). Effects of reducing the frequency and & duration criteria for binge eating on lifetime prevalence of bulimia nervosa and binge eating disorder: Implications for DSM-5. The International Journal of Eating Disorders, 45(4), 531–536.
Wade, T. D., Tiggemann, M., Bulik, C. M., Fairburn, C. G., Wray, N. R., & Martin, N. G. (2008). Shared temperament risk factors for anorexia nervosa: A twin study. Psychosomatic Medicine, 70(2), 239–244.
Walsh, B. T. (2008). Eating Disorders. In A. Tasman, J. Kay, J. A. Lieberman, M. B. First, & M. Maj (Eds.), Psychiatry (vol. 2, 3rd ed.pp. 1609–1625). West Sussex, UK: John Wiley & Sons, Ltd..
Walsh, B. T., Hadigan, C. M., Kissileff, H. R., & LaChaussée, J. L. (1992). Bulimia nervosa. A syndrome of feast and famine. In G. H. Anderson & S. H. Kennedy (Eds.), The biology of feast and famine. Relevance to eating disorders (pp. 1–20). San Diego, CA: Academic Press, Inc.
Walsh, B. T., Stewart, J. W., Roose, S. P., Gladis, M., & Glassman, A. H. (1985). A double-blind trial of phenelzine in bulimia. Journal of Psychiatric Research, 19(2–3), 485–489.
Welch, S. L., & Fairburn, C. G. (1994). Sexual abuse and bulimia nervosa: Three integrated case control comparisons. The American Journal of Psychiatry, 151(3), 402–407.
Wilson, G. T., Fairburn, C. C., Agras, W. S., Walsh, B. T., & Kraemer, H. (2002). Cognitive-behavioral therapy for bulimia nervosa: Time course and mechanisms of change. Journal of Consulting and Clinical Psychology, 70(2), 267–274.
Wilson, G. T., & Zandberg, L. J. (2012). Cognitive-behavioral guided self-help for eating disorders: Effectiveness and scalability. Clinical Psychology Review, 32(4), 343–357.
Wiseman, C. V., Sunday, S. R., Klapper, F., Harris, W. A., & Halmi, K. A. (2001). Changing patterns of hospitalization in eating disorder patients. The International Journal of Eating Disorders, 30(1), 69–74.
Wolfe, B. E., Hannon-Engel, S. L., & Mitchell, J. E. (2012). Bulimia nervosa in DSM-5. Psychiatric Annals, 42, 406–409.
Zimmerli, E. J., Devlin, M. J., Kissileff, H. R., & Walsh, B. T. (2010). The development of satiation in bulimia nervosa. Physiology & Behavior, 100(4), 346–349.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Prusky, M., Shear, M., Attia, E. (2017). Anorexia Nervosa and Bulimia Nervosa in Children and Adolescents. In: Goldstein, S., DeVries, M. (eds) Handbook of DSM-5 Disorders in Children and Adolescents. Springer, Cham. https://doi.org/10.1007/978-3-319-57196-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-57196-6_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57194-2
Online ISBN: 978-3-319-57196-6
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)